Healthcare >> Analyst Interviews >> June 7, 2001

Late-stage Biotechnology Companies: John Sonnier – Prudential Securities

JOHN SONNIER is a Senior Biotechnology Analyst focusing on areas of infectious disease, transfusion medicine and neuroscience. Mr. Sonnier joined Prudential Securities in July 1999 via the acquisition of Vector Securities International, Inc., and is now part of the Prudential Vector Healthcare Group. Prior to joining Vector Securities International, Inc., in 1996, he spent eight years in the pharmaceutical industry at Johnson & Johnson and Baxter in a variety of sales, marketing and business development roles and, most recently, as the Senior Healthcare Planning Manager at Baxter Healthcare Corporation, Biotech Group. Mr. Sonnier received his BS degree in Business from the University of Southern Mississippi in 1987. Profile
TWST: At Prudential Securities, who is your client today and how is that

group of clients changing or evolving?

Mr. Sonnier: That's actually a provocative question for Prudential

because there